Health Benefits of Modificated Multiplatinum Derivatives as Strategies for Overcoming the Cisplatin Resistance

被引:0
|
作者
Ivanova, Stefka Achkova [1 ]
Obreshkova, Danka Petrova [1 ]
Peikova, Lili Plamenova [2 ]
机构
[1] Med Univ Pleven, Fac Pharm, Dept Pharmaceut Chem & Pharmacognosy, Kliment Ohridski Str 1, Pleven 5800, Bulgaria
[2] Med Univ Sofia, Fac Pharm, Dept Pharmaceut Chem, Sofia 1000, Bulgaria
关键词
PROGRESS; CANCER;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1776 / 1778
页数:3
相关论文
共 50 条
  • [1] Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies
    Shruthi, S.
    Shenoy, K. Bhasker
    CHEMISTRYSELECT, 2024, 9 (25):
  • [2] Overcoming cisplatin resistance
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (04) : 407 - 407
  • [3] Personal health records: Definitions, benefits, and strategies for overcoming barriers to adoption
    Tang, PC
    Ash, JS
    Bates, DW
    Overhage, JM
    Sands, DZ
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2006, 13 (02) : 121 - 126
  • [4] Overcoming cisplatin resistance in tumor cells
    Koeberle, Beate
    Sen, Vasily
    Hartwig, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S16 - S16
  • [5] Overcoming cisplatin resistance in chemotherapy by biomineralization
    Chen, Wei
    Xiao, Yun
    Liu, Xueyao
    Chen, Yanhong
    Zhang, Jiaojiao
    Xu, Xurong
    Tang, Ruikang
    CHEMICAL COMMUNICATIONS, 2013, 49 (43) : 4932 - 4934
  • [6] Overcoming cisplatin resistance with the bioreductive drug tirapazamine
    Monaghan, JE
    Stratford, IJ
    BRITISH JOURNAL OF CANCER, 1998, 78 : 35 - 35
  • [7] Pharmacological strategies for overcoming multidrug resistance
    Nobili, S.
    Landini, I.
    Giglioni, B.
    Mini, E.
    CURRENT DRUG TARGETS, 2006, 7 (07) : 861 - 879
  • [8] Reporting as resistance: Strategies for overcoming reporting
    Hailparn D.F.
    Hailparn M.
    Journal of Contemporary Psychotherapy, 1999, 29 (2) : 155 - 165
  • [9] Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
    Chunjing Wu
    Medhi Wangpaichitr
    Lynn Feun
    Marcus Tien Kuo
    Carlos Robles
    Theodore Lampidis
    Niramol Savaraj
    Molecular Cancer, 4
  • [10] The mechanisms of mTOR inhibitor overcoming cisplatin resistance.
    Wu, Chunjing
    Wangpaichitr, Medhi
    Feun, Lynn
    Lampidis, Theodore
    Kuo, Marcus T.
    Robles, Carlos
    Savaraj, Niramol
    CANCER RESEARCH, 2006, 66 (08)